Mahmood Majeed, ZS, explains why measurable AI outcomes in pharma supply chain and manufacturing jumped from 29% to 53%, and how GMP limits and GxP validation shape adoption.
News|Articles|January 28, 2015
Recipharm Completes China-Focused Serialization Project
Author(s)Pharmaceutical Technology Editors
Recipharm has completed a serialization project for China on behalf of one of its customers.
Advertisement
CDMO Recipharm
Recipharm has developed a solution to ensure compliance with China’s serialization regulations and has supplied 57 serialized batches since February 2014. A new technology was applied to ensure that each individual box has its own one-dimensional barcode and unique serial number.
Source:
Advertisement
Related to this article
Science, circularity, regulation, and technology are reshaping how the industry develops packaging for medicines.
The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
Shubhajit Paul, a senior research fellow in Boehringer Ingelheim’s Department of Material Analytical Sciences, spoke with PharmTech at AAPS PharmSci 360 to explain how tabletability prediction can be improved for roller-compacted formulations.
This week on PharmTech.com, experts discussed E&L suitability standards, rare disease treatment development, sourcing ingredient suppliers, the use of AI in quality control, and more.
Cole and Jaenisch dig into AI poisoning in pharma manufacturing, how it hides in plain sight, and who should be accountable for catching it.
FDA approves GSK's bepirovirsen for chronic hepatitis B after a 19% functional cure rate, raising oligonucleotide scale-up stakes for manufacturers.
Advertisement
Advertisement